《睡眠專業人士雜誌》
星期四, 七月 23, 2026
Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Exclusivity (ODE) for Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solution, for the treatment of idiopathic hypersomnia in adults, making it the second ODE for the medication following the exclusivity granted in the treatment […]
Following months of collaborative development work, Aerogen® (Galway, Ireland) and CanSinoBIO (Tianjin, China) have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™ utilizing Aerogen’s proprietary vibrating mesh aerosol drug delivery technology. The aerosolized vaccine is directly inhaled via a cup […]
The Biden-Harris Administration is requiring COVID-19 vaccination of eligible staff at health care facilities that participate in the Medicare and Medicaid programs. The emergency regulation issued by the Centers for Medicare & Medicaid Services (CMS) today protects those fighting this virus on the front lines while also delivering assurances to […]
Purdue University and physIQ have announced the co-development of a viral detection algorithm for smartwatches. This innovation will be the result of a collaboration between physIQ and university engineers. The algorithm will be commercialized by physIQ, which develops solutions designed to improve health care outcomes by applying artificial intelligence to real-time physiological […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced positive data across multiple endpoints from a Phase 2 randomized, double-blind, placebo-controlled, four-period, single-dose crossover factorial clinical trial (APC-003), and a 28-day open-label extension study, evaluating AD109 as […]
The American College of Chest Physicians (CHEST), American Lung Association and American Thoracic Society released the following statement in response to the increase in COVID-19 cases and hospitalizations. “Recently, there has been a dramatic rise in COVID-19 hospitalizations due to the highly contagious Delta variant. According to the Centers for […]
The national plaintiffs’ law firm Berger Montague has filed a class action lawsuit against Dutch medical equipment company Philips to protect consumers harmed by Philips’ recalled sleep apnea machines, including CPAP and BiPAP machines, and ventilators, which may increase users’ risk of cancer and pulmonary fibrosis, and cause other injuries […]
By Matthew Perez, Victor Beauvil, RRT, PhD, Sarah Khan MD, Arunabh Talwar, MD, FCCP The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread quickly to all parts of the world, and this pandemic continues to result in significant morbidity and mortality. SARS-CoV-2 is one […]
Following the company update on 四月 26, 2021, Royal Philips has provided an update on the recall notification* for specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices to address identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component […]
Jazz Pharmaceuticals plc has announced positive results from the Phase 3 study of XywavTM (calcium, magnesium, potassium, and sodium oxybates) oral solution in adult patients with idiopathic hypersomnia, which will be presented during the Clinical Trials Plenary Session of the 2021 American Academy of Neurology (AAN) Annual Meeting. The presentation will further […]
